Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances α-synuclein fibril formation in vitro

K Ono, M Noguchi-Shinohara, M Yoshita, H Naiki… - Experimental …, 2007 - Elsevier
K Ono, M Noguchi-Shinohara, M Yoshita, H Naiki, M Yamada
Experimental neurology, 2007Elsevier
Deposition of α-synuclein (αS) aggregates inside brain cells is a pathological hallmark of
several neurodegenerative diseases, including Parkinson's disease (PD), and dementia
with Lewy bodies (DLB). Recently, extracellular αS was detected in cerebrospinal fluid
(CSF) and plasma of humans. We investigated whether CSF influences αS aggregation in
vitro using fluorescence spectroscopy with thioflavin S and electron microscopy. We found
that CSF obtained from Alzheimer's disease (AD) and DLB patients enhanced the αS fibril …
Deposition of α-synuclein (αS) aggregates inside brain cells is a pathological hallmark of several neurodegenerative diseases, including Parkinson's disease (PD), and dementia with Lewy bodies (DLB). Recently, extracellular αS was detected in cerebrospinal fluid (CSF) and plasma of humans. We investigated whether CSF influences αS aggregation in vitro using fluorescence spectroscopy with thioflavin S and electron microscopy. We found that CSF obtained from Alzheimer's disease (AD) and DLB patients enhanced the αS fibril formation compared with tauopathy and non-central nervous system disease. Thus, CSF of AD and DLB characterized by aggregation of Aβ or αS might promote fαS formation.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果